US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class II · Moderate risk Ongoing

Good Neighbor Pharmacy

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. NDC 24385-595-23 D-0561-2026
Class II · Moderate risk Ongoing

Good Neighbor Pharmacy

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. NDC 24385-106-80 D-0560-2026
Class II · Moderate risk Ongoing

Haleon Calcium Carbonate Tums Antacid

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. D-0559-2026
Class II · Moderate risk Ongoing

Haleon Calcium Carbonate Tums Antacid

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. D-0558-2026
Class II · Moderate risk Ongoing

KIRKLAND Signature

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. NDC 63981-171-80 D-0557-2026
Class II · Moderate risk Ongoing

Aripiprazole Tablets USP

Reason Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

Ajanta Pharma USA Inc NDC 27241-056-03 D-0594-2026
Class II · Moderate risk Ongoing

Alyacen 7/7/7

Reason Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

Glenmark Pharmaceuticals Inc., USA NDC 68462-556-29 D-0588-2026
Class II · Moderate risk Ongoing

Niacin Extended-release Tablets

Reason Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

Lannett Company Inc. NDC 62175-322-46 D-0584-2026
Class II · Moderate risk Ongoing

Xyvona

Reason Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona

Sun Pharmaceutical Industries INC NDC 72245-058-10 D-0599-2026
Class II · Moderate risk Ongoing

Xyvona

Reason Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona

Sun Pharmaceutical Industries INC NDC 72245-762-10 D-0598-2026
Class II · Moderate risk Ongoing

Zep, Alcohol Sanitizer Spray

Reason Microbial contamination of sterile products

Zep Inc NDC 66949-133-85 D-0586-2026
Class II · Moderate risk Ongoing

safco SensiCaine-Ultra

Reason Defective container:may contain bottles with incomplete seals

Keystone Industries NDC 67239-0223-1 D-0606-2026
Class II · Moderate risk Ongoing

PureLife

Reason Defective container:may contain bottles with incomplete seals

Keystone Industries NDC 68987-001-30 D-0605-2026
Class II · Moderate risk Ongoing

Dental City TOPICAL ANESTHETIC GEL

Reason Defective container:may contain bottles with incomplete seals

Keystone Industries NDC 69483-001-30 D-0604-2026
Class II · Moderate risk Ongoing

Burkhart topical anesthetic gel

Reason Defective container:may contain bottles with incomplete seals

Keystone Industries D-0603-2026
Class II · Moderate risk Ongoing

DHP Topical Anesthetic Gel

Reason Defective container:may contain bottles with incomplete seals

Keystone Industries NDC 69634-020-30 D-0602-2026
Class II · Moderate risk Ongoing

Quala Dental Products

Reason Defective container:may contain bottles with incomplete seals

Keystone Industries NDC 43128-034-30 D-0601-2026
Class II · Moderate risk Ongoing

Pearson Quality Topical Anesthetic Gel

Reason Defective container:may contain bottles with incomplete seals

Keystone Industries NDC 43305-0009-3 D-0600-2026
Class III · Low risk Ongoing

Lidocaine HCl Injection

Reason Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Eugia US LLC D-0552-2026
Class III · Low risk Ongoing

Pred Mild

Reason Failed Stability Specifications

AbbVie Inc. NDC 11980-174-10 D-0551-2026
Class II · Moderate risk Ongoing

VistaPharm

Reason Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

PAI Holdings LLC NDC 66689-203-08 D-0592-2026